JNBA Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $304K | Hold |
5,281
| – | – | 0.02% | 170 |
|
|
2026
Q1 | $320K | Sell |
5,281
-48
| -0.9% | -$2.8K | 0.03% | 166 |
|
|
2025
Q4 | $287K | Buy |
5,329
+31
| +0.6% | +$1.49K | 0.03% | 168 |
|
|
2025
Q3 | $239K | Sell |
5,298
-602
| -10% | -$28.1K | 0.02% | 170 |
|
|
2025
Q2 | $273K | Sell |
5,900
-179
| -3% | -$8.79K | 0.03% | 165 |
|
|
2025
Q1 | $371K | Buy |
6,079
+179
| +3% | +$10.4K | 0.04% | 143 |
|
|
2024
Q4 | $334K | Hold |
5,900
| – | – | 0.03% | 154 |
|
|
2024
Q3 | $305K | Hold |
5,900
| – | – | 0.03% | 161 |
|
|
2024
Q2 | $245K | Buy |
5,900
+250
| +4% | +$11.2K | 0.03% | 174 |
|
|
2024
Q1 | $306K | Sell |
5,650
-3
| -0.1% | -$153 | 0.03% | 167 |
|
|
2023
Q4 | $290K | Sell |
5,653
-944
| -14% | -$49.6K | 0.03% | 171 |
|
|
2023
Q3 | $383K | Buy |
6,597
+472
| +8% | +$28.9K | 0.05% | 142 |
|
|
2023
Q2 | $392K | Sell |
6,125
-845
| -12% | -$56.7K | 0.05% | 144 |
|
|
2023
Q1 | $483K | Buy |
6,970
+890
| +15% | +$62.8K | 0.06% | 131 |
|
|
2022
Q4 | $437K | Sell |
6,080
-300
| -5% | -$22.6K | 0.06% | 131 |
|
|
2022
Q3 | $454K | Sell |
6,380
-571
| -8% | -$41.4K | 0.07% | 126 |
|
|
2022
Q2 | $535K | Sell |
6,951
-195
| -3% | -$14.9K | 0.08% | 118 |
|
|
2022
Q1 | $522K | Hold |
7,146
| – | – | 0.07% | 124 |
|
|
2021
Q4 | $446K | Buy |
7,146
+3,105
| +77% | +$182K | 0.05% | 138 |
|
|
2021
Q3 | $239K | Hold |
4,041
| – | – | 0.03% | 179 |
|
|
2021
Q2 | $270K | Hold |
4,041
| – | – | 0.04% | 169 |
|
|
2021
Q1 | $255K | Buy |
4,041
+95
| +2% | +$5.91K | 0.04% | 169 |
|
|
2020
Q4 | $245K | Buy |
3,946
+75
| +2% | +$4.61K | 0.04% | 157 |
|
|
2020
Q3 | $233K | Sell |
3,871
-600
| -13% | -$36.1K | 0.05% | 145 |
|
|
2020
Q2 | $263K | Sell |
4,471
-2
| -0% | -$120 | 0.06% | 129 |
|
|
2020
Q1 | $249K | Hold |
4,473
| – | – | 0.06% | 123 |
|
|
2019
Q4 | $287K | Buy |
4,473
+391
| +10% | +$22.4K | 0.05% | 129 |
|
|
2019
Q3 | $207K | Buy |
4,082
+1,500
| +58% | +$70.5K | 0.04% | 143 |
|
|
2019
Q2 | $117K | Buy |
2,582
+100
| +4% | +$4.66K | 0.02% | 175 |
|
|
2019
Q1 | $118K | Hold |
2,482
| – | – | 0.03% | 168 |
|
|
2018
Q4 | $129K | Sell |
2,482
-10,543
| -81% | -$566K | 0.03% | 148 |
|
|
2018
Q3 | $809K | Buy |
13,025
+10,123
| +349% | +$601K | 0.36% | 60 |
|
|
2018
Q2 | $161K | Hold |
2,902
| – | – | 0.03% | 141 |
|
|
2018
Q1 | $184K | Buy |
2,902
+602
| +26% | +$38.7K | 0.04% | 130 |
|
|
2017
Q4 | $141K | Sell |
2,300
-435
| -16% | -$27.2K | 0.03% | 145 |
|
|
2017
Q3 | $174K | Buy |
2,735
+50
| +2% | +$2.92K | 0.04% | 129 |
|
|
2017
Q2 | $150K | Hold |
2,685
| – | – | 0.03% | 137 |
|
|
2017
Q1 | $146K | Buy |
2,685
+177
| +7% | +$9.71K | 0.03% | 142 |
|
|
2016
Q4 | $147K | Sell |
2,508
-10,419
| -81% | -$570K | 0.04% | 140 |
|
|
2016
Q3 | $697K | Buy |
12,927
+10,419
| +415% | +$669K | 0.1% | 68 |
|
|
2016
Q2 | $184K | Sell |
2,508
-39
| -2% | -$2.76K | 0.05% | 121 |
|
|
2016
Q1 | $163K | Buy |
2,547
+119
| +5% | +$7.5K | 0.06% | 117 |
|
|
2015
Q4 | $167K | Buy |
2,428
+1,360
| +127% | +$89.9K | 0.06% | 110 |
|
|
2015
Q3 | $63K | Buy |
1,068
+160
| +18% | +$10.2K | 0.03% | 165 |
|
|
2015
Q2 | $60K | Hold |
908
| – | – | 0.02% | 167 |
|
|
2015
Q1 | $59K | Sell |
908
-167
| -16% | -$10.5K | 0.02% | 169 |
|
|
2014
Q4 | $63K | Hold |
1,075
| – | – | 0.03% | 166 |
|
|
2014
Q3 | $55K | Buy |
1,075
+390
| +57% | +$19.5K | 0.02% | 180 |
|
|
2014
Q2 | $33K | Hold |
685
| – | – | 0.02% | 215 |
|
|
2014
Q1 | $36K | Sell |
685
-50
| -7% | -$2.66K | 0.02% | 193 |
|
|
2013
Q4 | $39K | Sell |
735
-430
| -37% | -$21.9K | 0.02% | 179 |
|
|
2013
Q3 | $54K | Buy |
1,165
+465
| +66% | +$20.4K | 0.03% | 157 |
|
|
2013
Q2 | $31K | Buy |
+700
| New | +$30.4K | 0.02% | 169 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
JNBA Financial Advisors's BMY Position: Q2 2026 in Review
JNBA Financial Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,281 shares worth $304K. The position accounts for 0.02% of the portfolio, ranked #170.
JNBA Financial Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $809K in Q3 2018. 852 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- JNBA Financial Advisors held 5,281 shares of Bristol-Myers Squibb worth $304K as of Q2 2026.
- JNBA Financial Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.02% of JNBA Financial Advisors's portfolio in Q2 2026, its #170 holding.
- JNBA Financial Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- JNBA Financial Advisors's Bristol-Myers Squibb position peaked at $809K in Q3 2018.
- 852 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.